MUSK and myasthenia gravis: Although the studies mentioned above demonstrate that MuSK antibody-positive MG and AChR antibody-positive MG have a variable response to rituximab, further studies are required to compare the efficacy and safety of RTX and relapse rate after treatment with RTX in MuSK MG and AChR MG.